The South African Rooibos Council got R4.5 million invested in research efforts. The research is aimed at studying its potential to reduce allergies, heart disease, diabetes, and skin cancer.
“Due to the large and growing use of natural derived substances for healthy living all over the world, it is imperative that the SARC obtains reliable data as to rooibos’ healing potential, since many other herbal-based treatments lack definitive evidence,” SARC research director Joe Swart said.
He also stated that the organisation wanted to provide the healthcare practitioners “with sufficient proof of rooibos”.
The 12-week-long trial will start in August. The findings will be published by the end of 2022.